US · Healthcare

Cellectar Biosciences Inc (CLRB)

Biotechnology

Cellectar Biosciences Inc (CLRB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CLRB

P/E ratio

18.00

Cellectar Biosciences Inc (CLRB) — FAQ

What is CLRB's P/E ratio?

The price-to-earnings (P/E) ratio for Cellectar Biosciences Inc (CLRB) is 18.00 (data as of 2026-03-23).

Does Cellectar Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cellectar Biosciences Inc (CLRB). Check the MyAverix Finance app for the latest dividend data.

What sector is Cellectar Biosciences Inc in?

Cellectar Biosciences Inc (CLRB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CLRB listed on?

CLRB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)